Concepedia

Joan Helmering

JH

Statistics

Publications

13

Citations

873

H-Index

13

Active since

2007

Affiliations

Amgen (United States)(Current)

Joan Helmering is an author at Amgen (United States) specializing in pharmacology, life sciences, and diabetes mellitus.

Publications per year

2007–2020

13

Publications

13

Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue

Murielle M. Véniant, Glenn Sivits, Joan Helmering et al. · Cell Metabolism · 2015 · 195 citations

, , +14

FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice

Murielle M. Véniant, Clarence Hale, Joan Helmering et al. · PLoS ONE · 2012 · 142 citations · Full text

, , +16

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism

Elizabeth A. Killion, Michelle Chen, James R. Falsey et al. · Nature Communications · 2020 · 136 citations · Full text

, , +17

Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors

David J. Lloyd, David J. St. Jean, Robert J. Kurzeja et al. · Nature · 2013 · 98 citations

, , +14

Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 3. Structure–Activity Relationships within the Aryl Carbinol Region of the <i>N</i>-Arylsulfonamido-<i>N</i>′-arylpiperazine Series

Nobuko Nishimura, Mark H. Norman, Longbin Liu et al. · Journal of Medicinal Chemistry · 2014 · 54 citations · Full text

, , +11

1–5 of 13